Climb Bio (CLYM) Preferred Shares (2021)

Climb Bio (CLYM) posted Preferred Shares of $147.1 million for Q2 2021, up 73.12% on a QoQ basis from $85.0 million in Q1 2021.

Climb Bio (CLYM) Preferred Shares (2021) Analysis & Trends

Climb Bio's Preferred Shares history runs 1 years deep, the most recent figure standing at $147.1 million for Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Climb Bio	870.33 Mn	870.33 Mn	-	-

Download Data

Date	Value
Jun 30, 2021	147.10 Mn
Mar 31, 2021	84.97 Mn